Literature DB >> 2901596

Amyloid precursor protein in senile plaques of Alzheimer disease.

G Perry, S Lipphardt, P Mulvihill, M Kancherla, M Mijares, P Gambetti, S Sharma, L Maggiora, J Cornette, T Lobl.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 2901596     DOI： 10.1016/s0140-6736(88)90219-x

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  25 in total

1.  Microtubule reduction in Alzheimer's disease and aging is independent of tau filament formation.

Authors:  Adam D Cash; Gjumrakch Aliev; Sandra L Siedlak; Akihiko Nunomura; Hisashi Fujioka; Xiongwei Zhu; Arun K Raina; Harry V Vinters; Massimo Tabaton; Anne B Johnson; Manuel Paula-Barbosa; Jesus Avíla; Paul K Jones; Rudy J Castellani; Mark A Smith; George Perry
Journal:  Am J Pathol       Date:  2003-05       Impact factor: 4.307

2.  Different configurational states of beta-amyloid and their distributions relative to plaques and tangles in Alzheimer disease.

Authors:  M G Spillantini; M Goedert; R Jakes; A Klug
Journal:  Proc Natl Acad Sci U S A       Date:  1990-05       Impact factor: 11.205

3.  Astrocytes in Alzheimer's disease gray matter express alpha 1-antichymotrypsin mRNA.

Authors:  J M Pasternack; C R Abraham; B J Van Dyke; H Potter; S G Younkin
Journal:  Am J Pathol       Date:  1989-11       Impact factor: 4.307

4.  Inhibition of amyloid precursor protein processing enhances gemcitabine-mediated cytotoxicity in pancreatic cancer cells.

Authors:  Neha Kabra Woods; Jaya Padmanabhan
Journal:  J Biol Chem       Date:  2013-09-10       Impact factor: 5.157

5.  Hypothesis: microtubules, a key to Alzheimer disease.

Authors:  S S Matsuyama; L F Jarvik
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

6.  The relationship of amyloid plaques to cerebral capillaries in Alzheimer's disease.

Authors:  M Kawai; R N Kalaria; S I Harik; G Perry
Journal:  Am J Pathol       Date:  1990-12       Impact factor: 4.307

7.  Quantitative phosphoproteomic analysis of neuronal intermediate filament proteins (NF-M/H) in Alzheimer's disease by iTRAQ.

Authors:  Parvathi Rudrabhatla; Philip Grant; Howard Jaffe; Michael J Strong; Harish C Pant
Journal:  FASEB J       Date:  2010-07-12       Impact factor: 5.191

8.  The beta-amyloid protein precursor of Alzheimer disease has soluble derivatives found in human brain and cerebrospinal fluid.

Authors:  M R Palmert; M B Podlisny; D S Witker; T Oltersdorf; L H Younkin; D J Selkoe; S G Younkin
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

Review 9.  Antioxidant therapy in Alzheimer's disease: theory and practice.

Authors:  Gjumrakch Aliev; Mark E Obrenovich; V Prakash Reddy; Justin C Shenk; Paula I Moreira; Akihiko Nunomura; Xiongwei Zhu; Mark A Smith; George Perry
Journal:  Mini Rev Med Chem       Date:  2008-11       Impact factor: 3.862

10.  Immunocytochemical evidence that the beta-protein precursor is an integral component of neurofibrillary tangles of Alzheimer's disease.

Authors:  G Perry; P L Richey; S L Siedlak; M A Smith; P Mulvihill; D A DeWitt; J Barnett; B D Greenberg; R N Kalaria
Journal:  Am J Pathol       Date:  1993-12       Impact factor: 4.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.